These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27730708)

  • 1. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols.
    Orzińska A; Krzemienowska M; Purchla-Szepioła S; Kopeć I; Guz K
    Transfusion; 2022 Apr; 62(4):863-870. PubMed ID: 35191535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
    Finning K; Martin P; Summers J; Daniels G
    Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
    Spence WC; Maddalena A; Demers DB; Bick DP
    J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kell typing by allele-specific PCR (ASP).
    Avent ND; Martin PG
    Br J Haematol; 1996 Jun; 93(3):728-30. PubMed ID: 8652402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applicability of different PCR-based methods for fetal RHD and K1 genotyping: a prospective study.
    Faas BH; Maaskant-Van Wijk PA; von dem Borne AE; van der Schoot CE; Christiaens GC
    Prenat Diagn; 2000 Jun; 20(6):453-8. PubMed ID: 10861708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
    Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
    Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American.
    Moulds JM; Persa R; Rierson D; Billingsley KL; Noumsi GT; Hue-Roye K; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2867-71. PubMed ID: 23581548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kell blood group system.
    Redman CM; Lee S
    Transfus Clin Biol; 1995; 2(4):243-9. PubMed ID: 8542022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women.
    Böhmova J; Vodicka R; Lubusky M; Holuskova I; Studnickova M; Kratochvilova R; Krejcirikova E; Janikova M; Durdová V; Dolezalová T; Filipová H; Dusek L; Dhaifalah I; Vomackova K; Kacerovsky M; Prochazka M; Vrtel R
    Fetal Diagn Ther; 2016; 40(1):48-53. PubMed ID: 26492079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors.
    Intharanut K; Khantisitthiporn O; Kupatawintu P; Leetrakool N; Mitundee S; Nathalang O
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel silent KEL alleles causing KEL:-5 (Ko) phenotype or discordance between KEL:1,-2 phenotype/KEL*01/02 genotype.
    Martin-Blanc S; Simon P; Gien D; Kappler-Gratias S; Le Pennec PY; Pham BN
    Transfusion; 2013 Nov; 53(11 Suppl 2):2859-66. PubMed ID: 23581578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
    Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
    Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of the Kell (K1) phenotype.
    Lee S; Wu X; Reid M; Zelinski T; Redman C
    Blood; 1995 Feb; 85(4):912-6. PubMed ID: 7849312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.